Document:

AGREEMENT
FOR THE PURCHASE OF COMMON STOCK AND PREFERRED STOCK

(Control
Block Agreement)

 

THIS
PURCHASE AGREEMENT, (this “Agreement”) made this 31st day of December, 2018, by and between Laurence Wainer,
an individual (the “Seller”), Blow & Drive Interlock Corporation, a Delaware corporation (the “Company”
or “BDIC”), and The Doheny Group, LLC a Nevada limited liability company (“Purchaser”),
setting forth the terms and conditions upon which Seller will sell to Purchaser and Purchaser will purchase from Seller certain
securities (the “Securities”) consisting of Eight Million Nine Hundred Twenty Four Thousand (8,924,000) shares
of Blow & Drive Interlock Corporation common stock (the “Common Shares”) and One Million (1,000,000) shares
of Blow & Drive Interlock Corporation. Series A Preferred Stock (the “Preferred Shares” and together with
the Common Shares, the “Shares”). Together the Sellers, BDIC and the Purchaser are referred to herein as the
“Parties.”

 

In
consideration of the mutual promises, covenants, and representations contained herein, THE PARTIES HERETO AGREE AS FOLLOWS:

 

WITNESSETH

 

WHEREAS,
the Sellers own the Shares, representing approximately 83.65% of the outstanding votes of the Company;

 

WHEREAS,
the Seller desires to sell, and the Purchaser desires to purchase, the Shares in accordance with the terms set forth herein;

 

WHEREAS,
the Parties desire and intend that the transactions contemplated by this Agreement will be a tax free reorganization under Section
368(a)(1)(B) of the Internal Revenue Code of 1986, as amended.

 

NOW
THEREFORE, in consideration of the premises and respective mutual agreements, covenants, representations and warranties herein
contained, it is agreed between the Parties hereto as follows:

 

ARTICLE
I

SALE
OF SECURITIES

 

1.01
Sale of the Shares. Subject to the terms and conditions of this Agreement, and the representation and warranties contained
herein, the Seller agrees to sell the Shares to the Purchaser for a total of Thirty Thousand Dollars (U.S.) ($30,000) (the “Purchase
Price”). This is a private transaction between the Seller and the Purchaser.

 

1.02
Payment: The Parties agree that the full Purchase Price will be wired on or before December 31, 2018 (the “Closing
Date”), to the Seller.

 

    	1

    	 

    

 

ARTICLE
II

REPRESENTATIONS
AND WARRANTIES

 

To
induce the Purchaser to enter into this Agreement and to consummate the transactions contemplated hereby, the Seller and the Company
represent and warrant as of the date hereof and as of the Closing, as follows:

 

2.01
Organization. BDIC is a Delaware corporation duly organized and validly existing, under the laws of that state, has all
necessary corporate powers to own properties and carry on a business. However, BDIC is not currently in good standing with the
State of Delaware as a result of not yet completing its financial statements for the year ended December 31, 2017. As a result,
the Company was not able to file its tax return for the tax year 2017. To the best knowledge of the Company and the Seller, all
other documents in the State of Delaware have been filed and once the financial statements for fiscal year 2017 are completed,
and any owed taxes are paid, the Company will be back in good standing in the State of Delaware. All actions taken by the incorporators,
directors and/or shareholders of BDIC have been valid and in accordance with the laws of the state of Delaware.

 

2.02
Capital. The authorized capital stock of BDIC consists of 100,000,000 shares of Common Stock, $0.0001 par value, of which
30,211,875 shares of Common Stock are issued and outstanding, and Twenty Million (20,000,000) shares of Preferred Stock, $0.001
par value, of which One Million (1,000,000) are designated as Series A Preferred Stock, all of which are outstanding. All outstanding
shares are fully paid and non-assessable, free of liens, encumbrances, options, restrictions and legal or equitable rights of
others not a party to this Agreement. At the Closing, only the subscriptions, options, rights, warrants, convertible securities,
or other agreements or commitments obligating BDIC to issue or to transfer from treasury any additional shares of its capital
stock, listed on Schedule 2.02 will be outstanding. None of the outstanding shares of BDIC are subject to any stock restriction
agreements. There are approximately 137 shareholders of record of BDIC and numerous shareholders that hold shares in a brokerage
account (street name). All of such shareholders have valid title to such shares and acquired their shares in a lawful transaction
and in accordance with Delaware corporate law and the applicable securities laws of the United States.

 

2.03
Subsidiaries. “Subsidiary” or “Subsidiaries” means all corporations, trusts, partnerships,
associations, joint ventures or other Persons, as defined below, of which a corporation or limited liability company or any other
Subsidiary of such corporation or limited liability company owns not less than twenty percent (20%) of the voting securities or
other equity or of which such corporation or limited liability company or any other Subsidiary of such corporation or limited
liability company possesses, directly or indirectly, the power to direct or cause the direction of the management and policies,
whether through ownership of voting shares, management contracts or otherwise. “Person” means any individual,
corporation, trust, association, partnership, proprietorship, joint venture or other entity. The Company has one wholly-owned
subsidiary, namely BDI Manufacturing, Inc., an Arizona corporation.

 

2.04
Financial Statements. The Company has historical audited financial statements and unaudited financial statements which
can be found on otcmarkets.com or www.sec.gov (Filings tab) under the Company’s name. The Company has supporting
documentation for all entries on its financial statements for the periods beginning March 31, 2014, and all financial statements
of the Company since that time were prepared in accordance with generally accepted accounting principles (GAAP).

 

    	2

    	 

    

 

2.05
Public Company Status. The Company is a reporting company under the Securities Exchange Act of 1934, as amended, is a public
company quoted on the OTC Markets, and has been assigned the trading symbol of “BDIC”. After the Purchase, the Purchaser
of the Shares shall file any required filing(s) disclosing the acquisition of the Shares by the Purchaser (“Disclosure
Document”) and the Company shall file any documents required to be filed by a company subject to the reporting requirements
of the Exchange Act.

 

2.06
Filings with Government Agencies. BDIC is a registered company under the Securities Exchange Act of 1934, as amended, (the
“Exchange Act”). The Company filed all required reports under the ’34 Act through its Quarterly Report
on Form 10-Q for the period ended September 30, 2017. The Company has not made the filings required under the Exchange
Act since its Quarterly Report on Form 10-Q for the period ended September 30, 2017, including, but not limited to, its Annual
Report on Form 10-K for the period ended December 31, 2017 and its Quarterly Reports on Form 10-Q for the periods ended March
31, 2018, June 30, 2018, and September 30, 2018 (the “Delinquent Filings”). BDIC has made all filings with
the state of Delaware that might be required. Upon the purchase of the Shares by the Purchaser, the Purchaser will have the full
responsibility for filing any and all documents required by the Securities and Exchange Commission, and/or any other government
agency that may be required. The Seller will supply the Purchaser with all information that is relevant for the Company, including
any information necessary to file the Delinquent Filings. After the Closing, the Purchaser understands that the Seller will have
no responsibility whatsoever for any filings made by the Company in the future, either with the SEC, FINRA, DTC or the State of
Delaware, but agrees to cooperate fully with the Purchaser in the event input or information is required from the Seller.

 

2.07
Shell Company Status. The company is not currently considered a “shell company” as such term is defined
in Section 405 of the Securities Act of 1933, as amended (the “Securities Act”).

 

2.08
Lawsuits. The Seller is not aware of any pending, threatened or asserted claims, lawsuits or contingencies involving the
Company or its securities. To the best of knowledge of the Sellers, there is no dispute of any kind between BDIC and any third
party.

 

2.09
Ability to Carry Out Obligations. The Seller has the right, power, and authority to enter into, and perform their obligations
under this Agreement. Except obligations owed to, and the required approval of, the Purchaser, the execution and delivery of this
Agreement by the Seller and the performance by the Seller of its obligations hereunder will not cause, constitute, or conflict
with or result in (a) any breach or violation of any of the provisions of or constitute a default under any license, indenture,
mortgage, charter, instrument, articles of incorporation, bylaws, or other agreement or instrument to which BDIC the officers,
directors or Sellers are a party, or by which they may be bound, nor will any consents or authorizations of any party other than
those hereto be required, (b) an event that would cause BDIC (and/or assigns) to be liable to any party, or (c) an event that
would result in the creation or imposition of any lien, charge, or encumbrance on any asset of BDIC or upon the Shares.

 

    	3

    	 

    

 

2.10
Contracts, Leases and Assets. BDIC is not a party to any contract, agreement or lease other than those agreements listed
on Schedule 2.10 (unless such contract, agreement or lease has been assigned to another party or BDIC has been released
from its obligations thereunder). No person holds a power of attorney from BDIC or the Seller.

 

2.11
Guaranties. The Company has not guaranteed any dividend, obligation or indebtedness of any person or legal entity; nor
has any person or legal entity guaranteed any dividend, obligation or indebtedness of the Company.

 

2.12
Compliance with Laws. To the best of knowledge of the Seller, BDIC has complied in all material respects, with, and is
not in violation of any, federal, state, or local statute, law, and/or regulation pertaining to its corporate organization and
its business. To the best of the knowledge of the Seller, BDIC has complied with all federal and state securities laws in connection
with the offer, sale and distribution of its securities. At the time that BDIC sold Shares to the Seller, the Company was entitled
to use the exemptions provided by the Securities Act relative to the sale of its securities, including, but not limited to, the
Shares. The Shares being sold herein are being sold in a private transaction between the Seller and the Purchaser, and the Seller
makes no representation as to whether the Shares are subject to trading restrictions under the Securities Act of 1933, as amended
and rules thereunder.

 

2.13
Litigation. BDIC is not a party to any suit, action, arbitration, or legal administrative, or other proceeding, or pending
governmental investigation. To the best knowledge of the Seller, there is no basis for any such action or proceeding and no such
action or proceeding is threatened against BDIC. BDIC is not a party to or in default with respect to any order, writ, injunction,
or decree of any federal, state, local, or foreign court, department, agency, or instrumentality.

 

2.14
Conduct of Business. Prior to the Closing, BDIC shall conduct its business in the normal course, and shall not (without
the prior written approval of Purchaser) (i) sell, pledge, or assign any assets, (ii) amend its Certificate of Incorporation or
Bylaws, (iii) declare dividends, or redeem, sell, or issue any stock or other securities (iv) incur any liabilities, except in
the normal course of business, (v) acquire or dispose of any assets, enter into any contract, guarantee obligations of any third
party, or (vi) enter into any other transaction.

 

2.15
Books and Records. Since March 31, 2014, the Company has kept its books, records and accounts (including, without limitation,
those kept for financial reporting purposes and for tax purposes) in accordance with good business practice and in sufficient
detail to reflect the transactions and dispositions of their assets, liabilities and equities. The minute books of the Company
contain records of their shareholders’ and directors’ meetings and of action taken by such shareholders and directors.
The meetings of directors and shareholders referred to in such minute books were duly called and held, and the resolutions appearing
in such minute books were duly adopted. The signatures appearing on all documents contained in such minute books are the true
signatures of the persons purporting to have signed the same.

 

2.16
Closing Documents. All articles, bylaws, minutes, consents or other documents pertaining to BDIC to be delivered at the
Closing shall be valid and in accordance with the laws of Delaware.

 

    	4

    	 

    

 

2.17
Title. The Seller has good and marketable title to all of the Shares being sold by it to the Purchaser pursuant to this
Agreement. The Securities will be, at the Closing, free and clear of all liens, security interests, pledges, charges, claims,
encumbrances and restrictions of any kind, except for restrictions on transfer imposed by federal and state securities laws and
any held by the Purchaser. None of the Securities are or will be subject to any voting trust or agreement. No person holds or
has the right to receive any proxy or similar instrument with respect to such Securities. Except as provided in this Agreement,
the Seller is not a party to any agreement which offers or grants to any person the right to purchase or acquire any of the Securities.
There is no applicable local, state or federal law, rule, regulation, or decree which would, as a result of the purchase of the
securities by Purchaser (and/or assigns) impair, restrict or delay voting rights with respect to the Securities.

 

2.18
Transfer of Shares. The Seller agrees to supply all necessary paperwork, including the share certificates representing
the Shares and medallion-guaranteed stock powers, or other sufficient transfer authorization, to transfer the Shares into the
Purchaser’s name and to actually transfer the Shares into the Purchaser’s name and deliver the physical certificates
to the Purchaser at the Closing.

 

2.19
No Amounts Owed. As of the Closing, no amounts will be due by the Company to the Seller for any reason, including, but
not limited to, for salary (accrued or otherwise) or repayment of debt.

 

2.20
Representations. All representations shall be true as of the Closing and all such representations shall survive the Closing.

 

ARTICLE
III

CLOSING

 

3.01
Closing for the Purchase of the Shares. The Closing (the “Closing”) of this transaction for the purchase of
the Shares will occur when all of the documents and consideration described in 3.02 below, have been delivered, or other arrangements
made and agreed to. Unless the Closing of this transaction takes place on or before December 31, 2018, then either party may terminate
this Agreement.

 

3.02
Documents and Payments to be Delivered at Closing of the Purchase. As part of the Closing of the purchase of the Shares,
the following documents, in form reasonably acceptable to counsel to the Parties, shall be delivered:

 

	 	(a)	By
    the Seller:

 

	 	(i)	Certificate
    of Incorporation and all amendments thereto (attached to Company’s filings on the EDGAR system);
	 	 	 
	 	(ii)	Bylaws
    and all amendments thereto (attached to Company’s filings on the EDGAR system);
	 	 	 
	 	(iii)	Minutes
    and Consents of Shareholders;
	 	 	 
	 	(iv)	Minutes
    and Consents of the board of directors;

 

    	5

    	 

    

 

	 	(v)	List
    of officers and directors;
	 	 	 
	 	(vi)	[left
    blank intentionally];
	 	 	 
	 	(vii)	Current
    Shareholder list from the Transfer Agent;
	 	 	 
	 	(viii)	True
    and correct copies of all of the business records of BDIC, including but not limited to correspondence files and agreements
    and contracts, and all banking information required for the Purchaser to access all Company bank accounts and credit accounts;
	 	 	 
	 	(ix)	Stock
    certificates in the name of the Seller, with restrictive legend, representing the Shares and executed stock powers sufficient
    to transfer the Shares to the Purchaser, including, but not limited to, a medallion-guaranteed stock power to transfer the
    shares of common stock representing that portion of the Shares;
	 	 	 
	 	(x)	Board
    of directors resolution appointing a new Chief Executive Officer, Secretary and Treasurer of the Company as designated by
    Purchaser;
	 	 	 
	 	(xi)	Board
    of directors resolution appointing new director(s) of BDIC as designated by the Purchaser;
	 	 	 
	 	(xii)	Board
    of directors resolution approving the signing of this Agreement by the Company and confirming the representations and warranties
    of the Company in this Agreement;
	 	 	 
	 	(xiii)	Acknowledgments
    of No Amounts Owed in the form attached hereto as Exhibits A and B, signed by the Seller and Michael Wainer; and
	 	 	 
	 	(xiv)	Such
    other documents of BDIC as may be reasonably required by Purchaser, if available.

 

	 	(b)
    	By
    Purchasers:

 

	 	(i)	Wire
    transfer to the Purchaser in the amount of $30,000, representing the total Purchase Price for the Shares, as instructed by
    the Seller.

 

    	6

    	 

    

 

3.03
Conditions Precedent. This Agreement, and the transactions contemplated hereby, shall be subject to the following conditions
precedent:

 

The
obligation of the Purchaser to pay the Purchase Price shall be subject to the fulfillment (or waiver by the Purchaser), at or
prior to the Closing or the applicable delivery date thereof, of the following conditions, which the Seller and the Company agree
to use their best efforts to cause to be fulfilled:

 

(a)
Representations, Performance. If the Closing Date is not the date hereof, the representations and warranties contained
in Article 2 hereof shall be true at and as of the date hereof and shall be repeated and shall be true at and as of the Closing
Date with the same effect as though made at and as of the Closing Date, except as affected by the transactions contemplated hereby;
the Sellers and the Company shall have duly performed and complied with all agreements and conditions required by this Agreement
to be performed or complied with by it prior to or on the Closing Date.

 

(b)
Consents. Any required consent to the transactions contemplated by this Agreement shall have been obtained or waived.

 

(c)
Litigation. No suit, action, arbitration or other proceeding or investigation shall be threatened or pending before any
court or governmental agency in which it is sought to restrain or prohibit or to obtain material damages or other material relief
in connection with this Agreement or the consummation of the transactions contemplated hereby or which is likely to affect materially
the value of the Shares or the Company.

 

(d)
Proceedings and Documentation. All corporate and other proceedings of the Company in connection with the transactions contemplated
by this Agreement, and all documents and instruments incident to such corporate proceedings, shall be satisfactory in form and
substance to the Purchaser and the Purchaser’s counsel, and the Purchaser and the Purchaser’s counsel shall have received
all such receipts, documents and instruments, or copies thereof, certified if requested, to which the Purchaser is entitled and
as may be reasonably requested.

 

(e)
Property Loss. No portion of BDIC’s assets shall have been destroyed or damaged or taken by condemnation under circumstances
where the loss thereof will not be substantially reimbursed to the Purchaser through the proceeds of applicable insurance or condemnation
award.

 

(f)
Consents and Approvals. All material licenses, permits, consents, approvals, authorizations, qualifications and orders
of governmental or regulatory bodies which are (1) necessary to enable the Purchaser to fully operate the business of BDIC as
contemplated from and after the Closing shall have been obtained and be in full force and effect, or (2) necessary for the consummation
of the transactions contemplated hereby, shall have been obtained. Any notices to or consents of any party to any agreement or
commitment constituting part of the transactions contemplated hereby, or otherwise required to consummate any such transactions,
shall have been delivered or obtained.

 

    	7

    	 

    

 

ARTICLE
IV

INVESTMENT
INTENT

 

4.01
Transfer Restrictions. The Purchaser (and/or assigns) agrees that the securities being acquired pursuant to this Agreement
may be sold, pledged, assigned, hypothecated or otherwise transferred, with or without consideration (“Transfer”)
only pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Act”),
or pursuant to an exemption from registration under the Act.

 

4.02.
Investment Intent. The Purchaser is acquiring the Shares for their own account for investment, and not with a view toward
distribution thereof.

 

4.03.
No Advertisement. The Purchaser acknowledges that the Shares have been offered to them in direct communication between
them and Seller, and not through any advertisement of any kind.

 

4.04.
Knowledge and Experience. (a) The Purchaser acknowledges that it has been encouraged to seek their own legal and financial
counsel to assist them in evaluating this purchase. The Purchaser is an “accredited investor”. The Purchaser acknowledges
that Seller has given them and all of their counselors access to all information relating to BDIC’s business that they or
any one of them have requested. The Purchaser acknowledges that it has sufficient business and financial experience, and knowledge
concerning the affairs and conditions of BDIC so that they can make a reasoned decision as to this purchase of the Shares and
are capable of evaluating the merits and risks of this purchase.

 

4.05.
Restrictions on Transferability. The Purchasers are aware of the restrictions on transferability of the Shares and further
understand the certificate representing these shares shall bear the following legend.

 

(a)
THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “ACT”), IN RELIANCE UPON THE EXEMPTION FROM REGISTRATION PROVIDED IN SECTIONS 4(A)(1) AND 4(A)(2) AND REGULATION
D UNDER THE ACT. AS SUCH, THE PURCHASE OF THIS SECURITY WAS MADE WITH THE INTENT OF INVESTMENT AND NOT WITH A VIEW FOR DISTRIBUTION.
THEREFORE, ANY SUBSEQUENT TRANSFER OF THIS SECURITY OR ANY INTEREST THEREIN WILL BE UNLAWFUL UNLESS IT IS REGISTERED UNDER THE
ACT OR UNLESS AN EXEMPTION FROM REGISTRATION IS AVAILABLE.

 

(b)
The Purchaser understands that these Shares may only be disposed of pursuant to either (i) an effective registration statement
under the Act, or (ii) an exemption from the registration requirements of the Act.

 

(c)
Neither BDIC nor the Seller have neither filed such a registration statement with the SEC or any state authorities nor agreed
to do so, nor contemplates doing so in the future, and in the absence of such a registration statement or exemption, the Purchaser
may have to hold the Shares indefinitely and may be unable to liquidate them in case of an emergency.

 

    	8

    	 

    

 

ARTICLE
V

COVENANTS

 

5.01
To induce the Purchaser to enter into this Agreement and to consummate the transactions contemplated hereby, and without limiting
any covenant, agreement, representation or warranty made, the Seller and the Company covenant and agree as follows:

 

(a)
Notices and Approvals. The Company and the Seller agree: (a) to give all notices to third parties which may be necessary
or deemed desirable by the Purchaser in connection with this Agreement and the consummation of the transactions contemplated hereby;
(b) to use their best efforts to obtain all federal and state governmental regulatory agency approvals, consents, permit, authorizations,
and orders necessary or deemed desirable by the Purchaser in connection with this Agreement and the consummation of the transactions
contemplated hereby; and (c) to use their best efforts to obtain all consents and authorizations of any other third parties necessary
or deemed desirable by the Purchaser in connection with this Agreement and the consummation of the transactions contemplated hereby.

 

(b)
Information for the Purchaser’s Statements and Applications. The Seller and the Company and their employees, accountants
and attorneys shall cooperate fully with the Purchaser in the preparation of any statements or applications made by the Purchaser
or the Company to any federal or state governmental regulatory agency in connection with this Agreement and the transactions contemplated
hereby and to furnish the Purchaser with all information concerning the Company and the Sellers necessary or deemed desirable
by the Purchaser for inclusion in such statements and applications, including, without limitation, all requisite financial statements
and schedules.

 

(c)
Access to Information. The Purchaser, together with his appropriate attorneys, agents and representatives, shall be permitted
to make the full and complete investigation of the Seller and the Company and have full access to all of the books and records
of the other during reasonable business hours. Notwithstanding the foregoing, such parties shall treat all such information as
confidential and shall not disclose such information without the prior consent of the other.

 

(d)
Non-Disparagement. The Parties acknowledge and agree that they will not defame or disparage the services, business, integrity,
veracity, or personal or professional reputation of the other Party or any the other Party’s directors, officers, employees,
affiliates, or agents of any of the foregoing in either a professional or personal manner; provided that the Parties may
testify and respond truthfully to any questions from or on behalf of the themselves or any of its affiliates, or in any legal
proceeding, arbitration or governmental investigation, or in any circumstances in which an answer may be legally compelled.

 

    	9

    	 

    

 

ARTICLE
VI

REMEDIES

 

6.01
Arbitration. Any controversy or claim arising out of, or relating to, this Agreement, or the making, performance, or interpretation
thereof, shall be settled by arbitration in California in accordance with the Rules of the U.S. Arbitration Association then existing,
and judgment on the arbitration award may be entered in any court having jurisdiction over the subject matter of the controversy.

 

6.02
Termination. In addition to any other remedies, the Purchaser may terminate this Agreement, if at the Closing, the Sellers
have failed to comply with all material terms of this Agreement have failed to supply any documents required by this Agreement
unless they do not exist, or have failed to disclose any material facts which could have a substantial effect on any part of this
transaction.

 

6.03
Indemnification. From and after the Closing, the Seller and the Purchaser, jointly and severally, agree to indemnify the
other against all actual losses, damages and expenses caused by (i) any material breach of this Agreement by them or any material
misrepresentation contained herein, or (ii) any misstatement of a material fact or omission to state a material fact required
to be stated herein or necessary to make the statements herein not misleading. Notwithstanding the above, if the Company attempts
to file the Delinquent Reports, then the Purchaser will only indemnify the Seller under this Section if the Seller uses good faith
efforts to assist the Company in filing the Delinquent Reports post-Closing.

 

6.04
Indemnification Non-Exclusive. The foregoing indemnification provision is in addition to, and not derogation of any statutory,
equitable or common law remedy any party may have for breach of representation, warranty, covenant or agreement.

 

6.05
Release by Purchaser. In consideration of this Agreement’s terms and conditions, the Purchaser, on behalf of itself
and its members and managers, assigns, attorneys, agents and representatives, and each of them, irrevocably and unconditionally
waives, releases, and promises never to assert against the Seller, and/or his attorneys, insurers, agents, successors, and assigns,
and each of them (collectively, the “Seller Releasees”), any and all debts, claims, liabilities, demands, and causes
of action of every kind, nature and description he may have against the Seller Releasees to the fullest extent permitted by law;
provided, however, that the Purchaser is not waiving any claims or rights that it may have under this Agreement. Additionally,
the Purchaser is not waiving or releasing any claims or rights that it may have against the Seller as a result of his fraudulent
or dishonest conduct, knowing or intentional violation of law.

 

6.06
Release by Seller. In consideration of this Agreement’s terms and conditions, the Seller, on behalf of himself and
his assigns, agents and representatives, and each of them, irrevocably and unconditionally waives, releases, and promises never
to assert against the Purchaser, and/or its managers, members, attorneys, insurers, agents, successors, and assigns, and each
of them (collectively, the “Purchaser Releasees”), any and all debts, claims, liabilities, demands, and causes of
action of every kind, nature and description he may have against the Purchaser Releasees to the fullest extent permitted by law;
provided, however, that the Seller is not waiving any claims or rights that he may have under this Agreement. Additionally, the
Seller is not waiving or releasing any claims or rights that he may have against the Purchaser as a result of its fraudulent or
dishonest conduct, knowing or intentional violation of law.

 

    	10

    	 

    

 

ARTICLE
VII

MISCELLANEOUS

 

7.01
Captions and Headings. The article and paragraph headings throughout this Agreement are for convenience and reference only,
and shall in no way be deemed to define, limit, or add to the meaning of any provision of this Agreement.

 

7.02
No Oral Change. This Agreement and any provision hereof, may not be waived, changed, modified, or discharged, orally, but
only by an agreement in writing signed by both Parties.

 

7.03
Non Waiver. Except as otherwise expressly provided herein, no waiver of any covenant, condition, or provision of this Agreement
shall be deemed to have been made unless expressly in writing and signed by the party against whom such waiver is charged; and
(i) the failure of any Party to insist in any one or more cases upon the performance of any of the provisions, covenants, or conditions
of this Agreement or to exercise any option herein contained shall not be construed as a waiver or relinquishment for the future
of any such provisions, covenants, or conditions, (ii) the acceptance of performance of anything required by this Agreement to
be performed with knowledge of the breach or failure of a covenant, condition, or provision hereof shall not be deemed a waiver
of such breach or failure, and (iii) no waiver by any Party of one breach by another Party shall be construed as a waiver with
respect to any other or subsequent breach.

 

7.04
Time of Essence. Time is of the essence of this Agreement and of each and every provision hereof.

 

7.05
Entire Agreement. This Agreement, including any and all attachments hereto, if any, and the Escrow Agreement contain the
entire agreement and understanding between the Parties, and supersede all prior agreements and understandings.

 

7.06
Significant Changes The Seller understands that significant changes may be made in the capitalization and/or stock ownership
of BDIC, which changes could involve a forward or reverse stock split and/or the issuance of additional shares, thus possibly
having a dramatic negative effect on the percentage of ownership and/or number of shares owned by present shareholders of BDIC.

 

7.07
Counterparts. This Agreement may be executed simultaneously in one or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument. Facsimile signatures will be acceptable to
all parties.

 

    	11

    	 

    

 

7.08
Notices. All notices, requests, demands, and other communications under this Agreement shall be in writing and shall be
deemed to have been duly given on the date of service if served personally on the party to whom notice is to be given, or on the
second day if faxed or sent by overnight mail, and properly addressed or faxed as follows:

 

If
to the Seller:

 

Laurence
Wainer

5503 Cahuenga Blvd, #203

Los
Angeles, CA 91601

Phone:
_________________

Fax:
___________________

E-mail:
laurenceorlarry@gmail.com

 

If
to the Company:

 

Blow
& Drive Interlock Corporation

5503
Cahuenga Blvd, #203

Los
Angeles, CA 91601

Attn.
President

Phone:
_________________

Fax:
___________________

E-mail:
info@blowanddrive.com

 

with
a copy to:

 

Law
Offices of Craig V. Butler

300
Spectrum Center Drive, Suite 300

Irvine,
CA 92618

Attn.
Craig V. Butler, Esq.

Phone:
(949) 484-5667

Fax:
(949) 209-2545

Email:
cbutler@craigbutlerlaw.com

 

If
to the Purchaser:

 

The
Doheny Group, LLC

1702
S. Robertson Boulevard #111

Los
Angeles, California 90035

Attention:
David Haridim, Managing Member

Phone: _________________

Fax: ___________________

E-mail: _________________

 

7.09
Binding Effect. This Agreement shall inure to and be binding upon the heirs, executors, personal representatives, successors
and assigns of each of the parties to this Agreement.

 

7.10
Effect of Closing. All representations, warranties, covenants, and agreements of the Parties contained in this Agreement,
or in any instrument, certificate, opinion, or other writing provided for in it, shall be true and correct as of the Closing and
shall survive the Closing of this Agreement.

 

    	12

    	 

    

 

7.11
Mutual Cooperation. The parties hereto shall cooperate with each other to achieve the purpose of this Agreement, and shall
execute such other and further documents and take such other and further actions as may be necessary or convenient to effect the
transaction described herein.

 

7.12
Expenses. Except as otherwise specifically provided for herein, whether or not the transactions contemplated hereby are
consummated, each of the Parties hereto shall bear the cost of all fees and expenses relating to or arising from its compliance
with the various provisions of this Agreement and such Party’s covenants to be performed hereunder, and except as otherwise
specifically provided for herein, each of the Parties hereto agrees to pay all of its own expenses (including, without limitation,
attorneys and accountants’ fees and printing expenses) incurred in connection with this Agreement, the transactions contemplated
hereby, the negotiations leading to the same and the preparations made for carrying the same into effect, and all such fees and
expenses of the Parties hereto shall be paid prior to Closing.

 

7.13
Finders’ and Related Fees. Each of the Parties hereto is responsible for, and shall indemnify the other against,
any claim by any third party to a fee, commission, bonus or other remuneration arising by reason of any services alleged to have
been rendered to or at the instance of said Party to this Agreement with respect to this Agreement or to any of the transactions
contemplated hereby.

 

7.14
Governing Law. This Agreement has been negotiated and executed in the State of California and shall be construed and enforced
in accordance with the laws of such state.

 

7.15
Forum. Each of the Parties hereto agrees that any action or suit which may be brought by any Party hereto against any other
Party hereto in connection with this Agreement or the transactions contemplated hereby may be brought only in a federal or state
court in Los Angeles County, California.

 

    	13

    	 

    

 

IN
WITNESS WHEREOF, this Agreement has been duly executed by the Parties as of the date first above written.

 

	“Seller”	 	“Purchaser”
	 	 	 
	Laurence
    Wainer	 	The
    Doheny Group, LLC
	an
    individual	 	a
    Nevada limited liability company
	 	 	 
	 	 	 
	Laurence
    Wainer	 	By:	           
		 	Its:	 

 

	As
    to the representations and warranties of the Company only:	 
	 	 
	“Company”	 
	 	 
	Blow
    & Drive Interlock Corporation,	 
	a
    Delaware corporation	 
	 	 	 
	 	 
	By:	Laurence
    Wainer	 
	Its:	President	 

 

    	14

    	 

    

 

Schedule
2.02

 

Outstanding
Convertible Instruments

 

The
following warrants to purchase the Company’s common stock are outstanding as of the Closing, and represent the only convertible
instruments the Company has outstanding as of the Closing:

 

A
summary of warrant activity for the periods presented is as follows:

 

	 	 	 	 	 	Weighted Average	 
	 	 	Warrants for Common Shares	 	 	Weighted Average
 Exercise Price	 	 	Remaining
 Contractual Term	 
	Outstanding as of December 31, 2018	 	 	5,137,298	 	 	$	0.46	 	 	$	2.38	 

 

    	15

    	 

    

 

Schedule
2.10

 

Material
Agreements

 

None.

 

    	16

    	 

    

 

Exhibit
A

 

Acknowledgment
of No Amounts Owed

 

Pursuant
to the terms of that certain Agreement for the Purchase of Common Stock and Preferred Stock (Control Block Agreement) (the “Agreement”)
by and between The Doheny Group, a Nevada limited liability company (the “Purchaser”), Laurence Wainer, an individual
(the “Seller”) and Blow & Drive Interlock Corporation, a Delaware corporation (the “Company”) dated
December 31, 2018, the Seller hereby acknowledges that as of the Closing under the Agreement he is not owed any amounts from the
Company for salary (accrued or otherwise), repayment of debt, or for any other reason, and that the consideration for making this
acknowledgment is the Purchase Price under the Agreement.

 

	Dated:
    December 31, 2018	By:	 
	 	 	Laurence
    Wainer

 

    	17

    	 

    

 

Exhibit
B

 

Acknowledgment
of No Amounts Owed

 

Pursuant
to the terms of that certain Agreement for the Purchase of Common Stock and Preferred Stock (Control Block Agreement) (the “Agreement”)
by and between The Doheny Group, a Nevada limited liability company (the “Purchaser”), Laurence Wainer, an individual
(the “Seller”) and Blow & Drive Interlock Corporation, a Delaware corporation (the “Company”) dated
December 31, 2018, the undersigned hereby acknowledges that as of the Closing under the Agreement he is not owed any amounts from
the Company for salary (accrued or otherwise), repayment of debt, or for any other reason.

 

	Dated:
    December 31, 2018	By:	 
	 	 	Michael
    Wainer

 

    	18Exhibit
4.1

 

NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND
THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN
SECURED BY SUCH SECURITIES.

 

COMMON
STOCK PURCHASE WARRANT

 

future
healthcare of america

 

	Warrant
    Shares: 33,000,000	Initial
    Exercise Date: October 19, 2018

 

THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Alpha Capital Anstalt or
its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after [the effective date of the Registration Statement (the “Initial Exercise
Date”) and on or prior to 5:00 p.m. (New York City time) on October 18, 2021 (the “Termination Date”)
but not thereafter, to subscribe for and purchase from Future Healthcare of America, a Wyoming corporation (the “Company”),
up to 33,000,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase
price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section
1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the “Purchase Agreement”), dated September 21, 2018, among the Company and the
purchasers signatory thereto.

 

Section
2. Exercise.

 

a)
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly
executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto
(the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days
comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid,
the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer
or cashier’s check drawn on a United States bank, unless the cashless exercise procedure specified in Section 2(c) below
is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion
guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein
to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender
this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is
delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant
Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in
an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of
Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.

 

     

     

    

 

b)
Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $0.060606, subject to adjustment
hereunder (the “Exercise Price”).

 

c)
Cashless Exercise. If at any time after the six-month anniversary of the Closing Date, there is no effective Registration
Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant
may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall
be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice
of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both
executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours”
(as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the
option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours”
on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular
trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice
of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

 

(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and

 

(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant
if such exercise were by means of a cash exercise rather than a cashless exercise.

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9)
of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period
of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.  The Company agrees not to
take any position contrary to this Section 2(c).

 

“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a
Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or
OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the
Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.

 

    2

     

    

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a
Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or
OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the
Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.

 

Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise
pursuant to this Section 2(c).

 

d)
Mechanics of Exercise.

 

i.
Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with
The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company
is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the
Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder
without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise
by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee,
for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder
in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the
Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number
of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date,
the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for
all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than
in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading
Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason
to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall
pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20
per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a
transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used
herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading
Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the
Notice of Exercise.

 

    3

     

    

 

ii.
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder
a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which
new Warrant shall in all other respects be identical with this Warrant.

 

iii.
Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv.
Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with
the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such
date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which
the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to
the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any)
for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that
the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell
order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion
of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company
timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company
shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall
limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

v.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.

 

vi.
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid
by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the
name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for
any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice
of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions)
required for same-day electronic delivery of the Warrant Shares.

 

    4

     

    

 

vii.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.

 

e)
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not
have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect
to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons,
“Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
below).  For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and
its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant
with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be
issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its
Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities
of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. 
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged
by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of
the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be
the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the
Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d)
of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the
number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected
in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent
public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the
number of shares of Common Stock outstanding.  Upon the written or oral request of a Holder, the Company shall within one
Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such
number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99%
of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock
issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon
exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the
Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company.
The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms
of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect
to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

    5

     

    

 

Section
3. Certain Adjustments.

 

a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities
payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company
upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines
(including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by
reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares,
if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding
immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted
such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a)
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b)
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata
to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will
be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could
have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before
the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase
Rights (provided, however, that, to the extent that the Holder’s right to participate in any such Purchase
Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate
in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right
to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

c)
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of
capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options
by way of a dividend, spin-off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall
be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder
had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a
record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common
Stock are to be determined for the participation in such Distribution (provided, however, that, to the extent that
the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any
shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in
abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation.

 

    6

     

    

 

d)
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell,
tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common
Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making
or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would
have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the
Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number
of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard
to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise
Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the
Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the
obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section
3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without
unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent
entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any
limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock
and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation
of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence
of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the
date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the “Company”
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the
obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity
had been named as the Company herein.

 

    7

     

    

 

e)
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

f)
Notice to Holder.

 

i.
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the
Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii.
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common
Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a
party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered
by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register
of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that
holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure
to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action
required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material,
non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the
period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.

 

    8

     

    

 

Section
4. Transfer of Warrant.

 

a)
Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d)
hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without
limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached
hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this
Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender
this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.

 

b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.

 

d)
Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant,
the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities
Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions
or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer,
that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.

 

e)
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a
view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable
state securities law, except pursuant to sales registered or exempted under the Securities Act.

 

Section
5. Miscellaneous.

 

a)
No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other
rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth
in Section 3.

 

    9

     

    

 

b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case
of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or stock certificate.

 

c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next
succeeding Business Day.

 

d)
Authorized Shares.

 

The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common
Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.
The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights
represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens
and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).

 

Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution,
issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the
terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.
Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above
the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares
upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions
or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform
its obligations under this Warrant.

 

Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be
necessary from any public regulatory body or bodies having jurisdiction thereof.

 

e)
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be determined in accordance with the provisions of the Purchase Agreement.

 

    10

     

    

 

f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities
laws.

 

g)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting
any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any
provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts
as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including
those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing
any of its rights, powers or remedies hereunder.

 

h)
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company
shall be delivered in accordance with the notice provisions of the Purchase Agreement.

 

i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability
of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.

 

j)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not
be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant
and shall be enforceable by the Holder or holder of Warrant Shares.

 

l)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holder.

 

m)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.

 

n)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.

 

********************

 

(Signature
Page Follows)

 

    11

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first
above indicated.

 

	 	future
    healthcare of america
	 	 
	 	By: 	/s/
    Chris Spencer
	 	 	Name: Chris Spencer
	 	 	Title: CEO

 

    12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]